This is a non-core endpoint: only basic statistics are computed.
Sequelae of injuries involving multiple and unspecified body regions
ST19_SEQUEL_INJURI_INVOLVI_MULTIPLE_UNSPE_BODY_REGIONS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
- Control exclude
- ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T9
- Name in latin
- Sequelae laesionum regionum corporis multarum sive non specificatarum
Similar endpoints
↥List of similar endpoints to
Sequelae of injuries involving multiple and unspecified body regions
based on the number of shared cases.
Similar with more cases:
- Sequelae of injuries, of poisoning and of other consequences of external causes
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 33 | 54 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 64.60 | 52.31 | 72.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 81
- Matched controls
- 811
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T94.0
ICD-10 Finland
Sequelae of injuries involving multiple body regions
+∞
81.6
64
*
T94.1
ICD-10 Finland
Sequelae of injuries, not specified by body region
+∞
19.6
18
*
Y89.1
ICD-10 Finland
Sequelae of war operations
227.8
18.3
18
*
X59
ICD-10 Finland
Exposure to unspecified factor
5.6
9.3
30
77
N03AX16
ATC
pregabalin; oral
5.5
9.0
29
74
T90.5
ICD-10 Finland
Sequelae of intracranial injury
+∞
8.5
8
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
13.8
7.9
13
11
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
13.8
7.9
13
11
E990A
ICD-9 Finland
Injury due to war operations by fires and conflagrations
43.9
6.9
8
*
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
+∞
6.3
6
*
9060A
ICD-9 Finland
Late effects of injuries to skin and subcutaneous tissues, Late effect of open wound of head, neck and trunk
+∞
6.3
6
*
M16.5
ICD-10 Finland
Other post-traumatic coxarthrosis
+∞
6.3
6
*
N03AX12
ATC
gabapentin; oral
5.0
6.2
20
50
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.2
6.1
16
31
N03AE01
ATC
clonazepam; systemic
7.9
6.0
13
19
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
28
158
2.14
2.58
3.6
2.1
376.07
177.93
u/l
0.41
28
145
16
73
2.46
2.38
1.9
2.0
2.39
2.39
g/l
0.00
16
64
26
150
2.05
2.23
3.2
2.3
54.77
55.82
u/l
0.06
26
140
6
15
4.21
2.07
4.5
3.0
25.53
24.64
mmol/l
—
6
15
8
26
3.28
2.07
1.0
1.0
—
—
—
0
0
15
72
2.31
2.00
1.7
2.0
17.79
25.45
%
—
10
57
16
80
2.23
1.95
1.9
2.0
7.91
15.05
umol/l
4.68
16
73
34
231
1.77
1.74
5.1
3.6
—
—
—
0
0
5
13
4.01
1.74
4.0
2.2
—
—
—
0
0
18
101
1.99
1.64
2.9
1.9
—
—
—
0
0
27
178
1.75
1.51
1.7
1.7
77.23
99.05
pmol/l
1.58
12
86
7
29
2.53
1.42
1.9
1.2
—
—
—
0
0
25
171
1.65
1.20
3.6
2.9
—
—
—
0
0
22
146
1.68
1.18
4.7
3.4
0.00
0.00
estimate
—
8
45
7
31
2.37
1.13
6.3
7.3
0.53
0.69
%
—
7
31
7
31
2.37
1.13
6.3
7.3
1.34
1.63
%
—
7
31
33
248
1.53
1.07
4.1
3.5
0.00
0.00
estimate
—
8
46
10
54
1.96
1.01
2.6
1.6
—
—
—
0
0
10
54
1.96
1.01
2.6
1.7
—
—
—
0
0
38
298
1.49
0.99
7.0
4.3
6.80
6.82
mmol/l
0.02
38
268
5
103
0.45
0.97
2.0
1.5
—
—
—
0
0
6
27
2.31
0.95
5.7
4.0
24.30
24.83
mmol/l
—
6
27
6
27
2.31
0.95
3.3
3.3
0.12
0.10
e6/l
—
6
27
45
375
1.41
0.82
3.8
3.8
14.88
14.81
pmol/l
0.06
38
334
32
251
1.43
0.81
5.1
4.8
0.00
0.00
estimate
—
8
45
42
492
0.72
0.77
26.9
13.1
38.34
39.98
%
0.82
27
373
32
254
1.41
0.75
4.2
3.6
0.00
0.00
estimate
—
8
41
60
533
1.41
0.71
24.8
14.5
4.03
3.97
mmol/l
1.14
60
507
5
27
1.90
0.69
1.6
1.3
—
—
—
0
0
11
71
1.63
0.66
3.9
2.5
0.20
1.43
e6/l
—
6
38
11
71
1.63
0.66
2.5
1.8
—
—
—
0
0
59
528
1.36
0.63
25.3
14.5
139.27
139.71
mmol/l
0.62
59
504
10
64
1.64
0.61
4.8
2.8
1.00
3.38
e6/l
—
5
32
35
292
1.33
0.59
9.1
10.7
4.59
4.31
e9/l
0.22
30
252
58
524
1.32
0.54
20.3
12.8
27.19
23.53
mg/l
0.28
53
401
25
204
1.32
0.48
4.8
3.5
—
—
—
0
0
60
551
1.29
0.45
22.8
14.8
75.65
78.56
umol/l
0.43
60
551
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
2.4
—
171.15
—
0
10
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
192.38
—
0
8
6
41
1.50
0.37
1.5
2.0
345.67
395.11
nmol/l
—
6
36
7
56
1.27
0.30
2.4
4.9
1.05
1.09
mmol/l
—
7
49
49
527
0.84
0.29
4.2
4.8
2.74
2.73
mmol/l
0.02
41
479
8
63
1.30
0.29
2.4
2.4
12.50
7.51
umol/l
—
8
53
41
446
0.85
0.27
29.4
16.1
13.80
13.67
%
0.25
41
435
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
22.31
—
0
10
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
49
517
0.88
0.18
3.9
4.3
1.45
1.47
mmol/l
0.12
41
470
49
516
0.88
0.17
3.8
4.3
4.57
4.64
mmol/l
0.17
42
475
11
94
1.19
0.14
1.5
1.4
—
—
—
0
0
48
499
0.92
0.11
3.3
3.9
1.50
1.27
mmol/l
0.70
41
457
60
582
1.10
0.10
29.6
19.4
132.02
136.04
g/l
1.04
60
569
49
472
1.09
0.10
4.6
4.3
1.88
1.94
mu/l
0.14
44
421
6
55
1.10
0.09
4.0
3.4
—
—
—
0
0
10
113
0.87
0.09
1.5
1.2
0.32
1.93
u/ml
—
5
29
5
61
0.81
0.08
4.2
8.6
—
—
—
0
0
5
63
0.78
0.08
2.2
2.7
—
—
—
0
0
50
485
1.07
0.07
19.5
12.3
85.69
83.36
ml/min/173m2
0.30
42
382
34
350
0.95
0.03
3.3
3.4
—
—
—
0
0
50
502
0.99
0.00
4.0
4.3
7.02
5.97
mmol/l
0.49
45
454
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
13.40
—
0
5
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
5
56
0.89
0.00
2.2
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
13.17
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
0.98
—
0
5
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_SEQUEL_INJURI_INVOLVI_MULTIPLE_UNSPE_BODY_REGIONS – Sequelae of injuries involving multiple and unspecified body regions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).